Assay News and Research

RSS

AquaStar granted U.S. Patent for Portable Capillary Sensor technology used in Capwave ELISA platform

AquaStar Holdings, Inc. is pleased to announce that the United States Patent and Trademark Office has issued patent number 7,708,944 for the Ultra-Sensitive, Portable Capillary Sensor technology utilized by the Capwave Enzyme-Linked Immuno-Sorbent Assay (ELISA) platform.

28 Apr 2011

Researchers begin approved drugs screening for clinical use against rare diseases

Researchers have begun screening the first definitive collection of thousands of approved drugs for clinical use against rare and neglected diseases. They are hunting for additional uses of the drugs hoping to find off-label therapies, for some of the 6,000 rare diseases that afflict 25 million Americans.

28 Apr 2011

TB screening misses immigrants: Study

According to a latest study published in The Lancet, one in five new immigrants to the UK from the Indian subcontinent, and almost a third from sub-Saharan Africa, carried latent tuberculosis (TB).

28 Apr 2011

New screening marker can detect pancreatic cancer

Researchers at the University of Michigan Comprehensive Cancer Center have identified a protein that shows distinct changes in structure between pancreatic cancer, non-cancerous diseases and normal blood serum. The protein also changes from early stage pancreatic cancer to advanced disease.

28 Apr 2011

Affymetrix reports total revenue of $73.7 million for first quarter 2011

Affymetrix, Inc., today reported its operating results for the first quarter of 2011. Total revenue for the quarter was $73.7 million, as compared to total revenue of $80.2 million in the first quarter of 2010.

28 Apr 2011

Nationwide researchers to launch Oncotype DX test phase III trial in breast cancer

Cancer researchers at hundreds of sites nationwide are about to launch a SWOG-led clinical trial that could keep thousands of breast cancer patients from getting chemotherapy that is unlikely to do them any good.

27 Apr 2011

Biomagnetics signs agreement with LANL to develop validated TB biomarker assay

Biomagnetics Diagnostics Corp., (PINK SHEETS: BMGP) a developer of revolutionary diagnostic systems and related technology for detecting HIV, hepatitis, tuberculosis, cholera and malaria, and other innovative technologies, today announced it has now completed a series of payments to Los Alamos National Laboratory (LANL) pursuant to the cooperative research and development agreement (CRADA) executed in 2010 between the two organizations.

21 Apr 2011

Gen-Probe receives FDA marketing clearance for APTIMA Trichomonas vaginalis assay

Gen-Probe Incorporated announced today that the US Food and Drug Administration (FDA) has cleared for marketing its APTIMA® Trichomonas vaginalis assay on the fully automated TIGRIS® system.

20 Apr 2011

Chembio initiates FDA Modular PMA process for DPP HIV 1/2 Screening Assay

Chembio Diagnostics, Inc., which develops, manufactures, markets and licenses point-of-care diagnostic tests, reported it recently filed the first module of its Pre-Marketing Approval (PMA) application to the United States Food & Drug Administration for its DPP® HIV 1/2 Screening Assay.

19 Apr 2011

Scientists identify networks of genes critical in embryonic-heart development

Scientists at the Gladstone Institutes have identified networks of genes that play an important role in embryonic-heart development, advancing knowledge of how healthy hearts develop-and offering clues about how to combat a common birth defect known as congenital heart disease.

18 Apr 2011

CHMP adopts EU positive opinion for TYSABRI labeling with anti-JCV antibody status

Biogen Idec and Elan Corporation, plc today announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion for inclusion of an additional risk factor, anti-JC virus (JCV) antibody status, to the product label for TYSABRI in the European Union.

18 Apr 2011

GRAVITAS study shows no benefit of double-dose compared with standard-dose clopidogrel

An international consortium of scientists, including major contributions from the Montreal Heart Institute, demonstrates that the "one-size fits all" strategy of uniformly doubling the dose of an antiplatelet drug, clopidogrel, for patients with high on-treatment platelet reactivity does not reduce the incidence on death, heart attacks and stent thrombosis after percutaneous coronary intervention.

16 Apr 2011

Abbott submits ARCHITECT 25-OH Vitamin D assay application to FDA for clearance

According to a recent report from the U.S. Centers for Disease Control and Prevention, a third of Americans have vitamin D levels that are either inadequate or deficient. While many people know that vitamin D is necessary to help the body absorb calcium, which helps create strong bones and muscles, many don't know that insufficient levels of this important vitamin may lead to other health problems.

16 Apr 2011

SQI enters clinical validation agreement with University North Carolina Kidney Center for Vasculitis Assay

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based autoimmune biomarker testing, today announced it entered into a clinical validation agreement with University North Carolina Kidney Center, Chapel Hill, to evaluate SQI's new multiplexed, automated approach for biomarker detection in vasculitis.

15 Apr 2011

NRC, NCKU partner to develop cancer diagnostic and treatment technologies

A Taiwanese research team led by Prof. Dar-Bin Shieh of Institute of Oral Medicine in Medical College at National Cheng Kung University has partnered with a research group led by Dr. Dennis Whitefield from National Research Council of Canada to develop innovative cancer diagnostic and treatment technologies.

15 Apr 2011

Enigma initiates ML system trial in patients with influenza

Enigma Diagnostics announced today that it has commenced clinical trials for its intended point of care Enigma ML Influenza A/B detection assay. Enigma will submit its application to the U.S. Food and Drug Administration for approval of the assay in 2012.

11 Apr 2011

Cellix expands European distribution network with Tebu-bio

Cellix are pleased to announce the signing of a distribution agreement with tebu-bio SAS. tebu-bio has a well-established pan-European presence, recognised by the international scientific community with local offices in France, Germany, Belgium, the Netherlands, Italy, Denmark, Portugal, Spain and the UK.

11 Apr 2011

Cepheid receives FDA clearance for new assay to detect C. difficile infection

The U.S. Food and Drug Administration today cleared a test called the Cepheid Xpert C. difficile/Epi assay that is designed to rapidly detect the toxin B gene associated with Clostridium difficile infection, a cause of diarrhea that can lead to colitis, other serious intestinal conditions and death in severe cases.

11 Apr 2011

Gene expression changes in prostate tissue surrounding cancer lesions may allow prostate cancer diagnosis

Researchers have found that gene expression changes in prostate tissue surrounding cancer lesions may allow diagnosis of prostate cancer even if no cancer cells are present in biopsy tissue, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.

8 Apr 2011

ChanTest to provide new system for LGIC and VGIC screening

Beginning next month, ChanTest Corporation will offer the highest throughput electrophysiology platform on the market validated for both voltage-gated and rapidly desensitizing ligand-gated ion channels.

7 Apr 2011

Assay News and Research

AquaStar granted U.S. Patent for Portable Capillary Sensor technology used in Capwave ELISA platform

Researchers begin approved drugs screening for clinical use against rare diseases

TB screening misses immigrants: Study

New screening marker can detect pancreatic cancer

Affymetrix reports total revenue of $73.7 million for first quarter 2011

Nationwide researchers to launch Oncotype DX test phase III trial in breast cancer

Biomagnetics signs agreement with LANL to develop validated TB biomarker assay

Gen-Probe receives FDA marketing clearance for APTIMA Trichomonas vaginalis assay

Chembio initiates FDA Modular PMA process for DPP HIV 1/2 Screening Assay

Scientists identify networks of genes critical in embryonic-heart development

CHMP adopts EU positive opinion for TYSABRI labeling with anti-JCV antibody status

GRAVITAS study shows no benefit of double-dose compared with standard-dose clopidogrel

Abbott submits ARCHITECT 25-OH Vitamin D assay application to FDA for clearance

SQI enters clinical validation agreement with University North Carolina Kidney Center for Vasculitis Assay

NRC, NCKU partner to develop cancer diagnostic and treatment technologies

Enigma initiates ML system trial in patients with influenza

Cellix expands European distribution network with Tebu-bio

Cepheid receives FDA clearance for new assay to detect C. difficile infection

Gene expression changes in prostate tissue surrounding cancer lesions may allow prostate cancer diagnosis

ChanTest to provide new system for LGIC and VGIC screening

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News